Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols

Abstract This study evaluated dynamics of antibodies in dogs treated for canine visceral leishmaniasis (CVL). Twenty-one dogs naturally infected by Leishmania spp. were grouped based on the treatment protocol: G1 (n=4) received allopurinol; G2 (n=10) allopurinol with miltefosine; and G3 (n=7) allopu...

Full description

Saved in:
Bibliographic Details
Main Authors: Eliesse Pereira Costa, Gisele Vaz Aguirre Samoel, Gilneia da Rosa, Vanessa Osmari, Michelli Lopes de Souza, Luís Felipe Dias Lopes, Fernanda Silveira Flôres Vogel, Sônia de Avila Botton, Luís Antônio Sangioni
Format: Article
Language:English
Published: Colégio Brasileiro de Parasitologia Veterinaria 2025-01-01
Series:Revista Brasileira de Parasitologia Veterinária
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-29612025000100800&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841538765849362432
author Eliesse Pereira Costa
Gisele Vaz Aguirre Samoel
Gilneia da Rosa
Vanessa Osmari
Michelli Lopes de Souza
Luís Felipe Dias Lopes
Fernanda Silveira Flôres Vogel
Sônia de Avila Botton
Luís Antônio Sangioni
author_facet Eliesse Pereira Costa
Gisele Vaz Aguirre Samoel
Gilneia da Rosa
Vanessa Osmari
Michelli Lopes de Souza
Luís Felipe Dias Lopes
Fernanda Silveira Flôres Vogel
Sônia de Avila Botton
Luís Antônio Sangioni
author_sort Eliesse Pereira Costa
collection DOAJ
description Abstract This study evaluated dynamics of antibodies in dogs treated for canine visceral leishmaniasis (CVL). Twenty-one dogs naturally infected by Leishmania spp. were grouped based on the treatment protocol: G1 (n=4) received allopurinol; G2 (n=10) allopurinol with miltefosine; and G3 (n=7) allopurinol, miltefosine and Leish-Tec® vaccine. The dogs were monitored monthly for a period of one year. To verify serum antibody titers, an indirect immunofluorescence reaction was performed. We found that dogs from G1 and G2 had lower clinical scores and antibody titers, when compared to the parameters evaluated in pre-treatment; however, clinical relapses were observed in three animals. In G3, clinical scores were lower than pre-treatment; however, they presented relatively stable antibody titers and no clinical relapse was observed. All animals submitted to the evaluated treatment protocols showed relative improvement in clinical signs. Furthermore, the immune response of animals must be considered, given the challenges of parasitic loads in infections. Therefore, it is necessary to complement the methods of clinical and therapeutic monitoring of dogs with CVL in order to establish the risk of transmissibility of the agent in infected and treated dogs.
format Article
id doaj-art-53b3e98968124728bfdb74cbcc7efbf1
institution Kabale University
issn 1984-2961
language English
publishDate 2025-01-01
publisher Colégio Brasileiro de Parasitologia Veterinaria
record_format Article
series Revista Brasileira de Parasitologia Veterinária
spelling doaj-art-53b3e98968124728bfdb74cbcc7efbf12025-01-14T07:39:38ZengColégio Brasileiro de Parasitologia VeterinariaRevista Brasileira de Parasitologia Veterinária1984-29612025-01-0134110.1590/s1984-29612025001Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocolsEliesse Pereira CostaGisele Vaz Aguirre SamoelGilneia da RosaVanessa OsmariMichelli Lopes de SouzaLuís Felipe Dias LopesFernanda Silveira Flôres VogelSônia de Avila BottonLuís Antônio Sangionihttps://orcid.org/0000-0002-2364-1084Abstract This study evaluated dynamics of antibodies in dogs treated for canine visceral leishmaniasis (CVL). Twenty-one dogs naturally infected by Leishmania spp. were grouped based on the treatment protocol: G1 (n=4) received allopurinol; G2 (n=10) allopurinol with miltefosine; and G3 (n=7) allopurinol, miltefosine and Leish-Tec® vaccine. The dogs were monitored monthly for a period of one year. To verify serum antibody titers, an indirect immunofluorescence reaction was performed. We found that dogs from G1 and G2 had lower clinical scores and antibody titers, when compared to the parameters evaluated in pre-treatment; however, clinical relapses were observed in three animals. In G3, clinical scores were lower than pre-treatment; however, they presented relatively stable antibody titers and no clinical relapse was observed. All animals submitted to the evaluated treatment protocols showed relative improvement in clinical signs. Furthermore, the immune response of animals must be considered, given the challenges of parasitic loads in infections. Therefore, it is necessary to complement the methods of clinical and therapeutic monitoring of dogs with CVL in order to establish the risk of transmissibility of the agent in infected and treated dogs.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-29612025000100800&lng=en&tlng=enInfectionLeishmaniapublic healthzoonosis
spellingShingle Eliesse Pereira Costa
Gisele Vaz Aguirre Samoel
Gilneia da Rosa
Vanessa Osmari
Michelli Lopes de Souza
Luís Felipe Dias Lopes
Fernanda Silveira Flôres Vogel
Sônia de Avila Botton
Luís Antônio Sangioni
Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols
Revista Brasileira de Parasitologia Veterinária
Infection
Leishmania
public health
zoonosis
title Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols
title_full Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols
title_fullStr Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols
title_full_unstemmed Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols
title_short Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols
title_sort antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols
topic Infection
Leishmania
public health
zoonosis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-29612025000100800&lng=en&tlng=en
work_keys_str_mv AT eliessepereiracosta antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT giselevazaguirresamoel antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT gilneiadarosa antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT vanessaosmari antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT michellilopesdesouza antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT luisfelipediaslopes antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT fernandasilveirafloresvogel antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT soniadeavilabotton antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols
AT luisantoniosangioni antibodydynamicsindogssubmittedtodifferentcaninevisceralleishmaniasistreatmentprotocols